blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4360619

EP4360619 - DOSAGE FORM FOR INTRA-ARTICULAR INJECTION COMPRISING COLCHICINE AND AN ANESTHESIC AGENT IN THE TREATMENT OF CRYSTAL-AND NON-CRYSTAL ASSOCIATED ACUTE INFLAMMATORY ARTHRITIS [Right-click to bookmark this link]
StatusThe application has been published
Status updated on  29.03.2024
Database last updated on 03.10.2024
Most recent event   Tooltip09.05.2024New entry: Despatch of communication that application is refused 
Applicant(s)For all designated states
PK MED
12-14 rue Jean Antoine de Baif
75013 Paris / FR
[2024/18]
Representative(s)Cabinet Nony
11 rue Saint-Georges
75009 Paris / FR
[2024/18]
Application number, filing date22306613.525.10.2022
[2024/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4360619
Date:01.05.2024
Language:EN
[2024/18]
Search report(s)(Supplementary) European search report - dispatched on:EP06.04.2023
ClassificationIPC:A61K9/00, A61K31/165, A61K31/445, A61K47/34, A61P29/00, A61P19/02, A61K9/10, // A61K9/16
[2024/18]
CPC:
A61P19/02 (EP); A61K31/165 (EP); A61K31/167 (EP);
A61K31/445 (EP); A61K45/06 (EP); A61K9/0019 (EP);
A61P29/00 (EP); A61K9/1647 (EP) (-)
C-Set:
A61K31/165, A61K2300/00 (EP);
A61K31/167, A61K2300/00 (EP);
A61K31/445, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   ME,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/18]
Extension statesBANot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:DARREICHUNGSFORM FÜR INTRAARTIKULÄRE INJEKTION MIT COLCHICIN UND EINEM ANÄSTHETIKUM BEI DER BEHANDLUNG VON KRISTALL- UND NICHTKRISTALLASSOZIIERTER AKUTER ENTZÜNDLICHER ARTHRITIS[2024/18]
English:DOSAGE FORM FOR INTRA-ARTICULAR INJECTION COMPRISING COLCHICINE AND AN ANESTHESIC AGENT IN THE TREATMENT OF CRYSTAL-AND NON-CRYSTAL ASSOCIATED ACUTE INFLAMMATORY ARTHRITIS[2024/18]
French:FORME POSOLOGIQUE POUR INJECTION INTRA-ARTICULAIRE COMPRENANT DE LA COLCHICINE ET UN AGENT ANESTHÉSIQUE DANS LE TRAITEMENT DE L'ARTHRITE INFLAMMATOIRE AIGUË ASSOCIÉE AUX CRISTAUX ET AUX NON-CRISTAUX[2024/18]
Examination procedure10.05.2024Despatch of communication that the application is refused, reason: Examination on filing A.90(5) {1}
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XDYI]US5747060  (SACKLER RICHARD [US], et al) [XD] 1-9,11-14 * claims 1, 4, 5, 6, 8, 9, 11, 13 * * column 3, line 36 - line 38 * * column 4, line 40 - line 49 * * column 5, line 35 - line 43 * * column 7, line 7 - line 35 * * column 7, line 58 - column 8, line 5 * * column 10, line 54 - line 63 * * column 10, line 66 - column 11, line 4 * * column 13, line 41 - line 55 * * column 16, line 7 - line 16 * * column 16, line 23 - line 25 * * column 17, line 34 - column 18, line 43; example 1 * * column 18, line 45 - column 19, line 57; tables I-II * [Y] 17-22 [I] 10,15,16;
 [Y]US2002054915  (GOLDENHEIM PAUL [US], et al) [Y] 17-22 * claims 1, 2, 3, 4, 8, 15 * * paragraph [0060] * * paragraph [0135] * * paragraph [0147] * * paragraph [0157] * * paragraph [0187] - paragraph [0189]; example 12; table 3 *;
 [T]  - BURT HELEN M ET AL, "Intra-articular drug delivery systems: Overcoming the shortcomings of joint disease therapy.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (200901), Database accession no. NLM19236205, XP002808823 [T] 1-22 * the whole document *
    [ ] - BURT HELEN M ET AL, "Intra-articular drug delivery systems: Overcoming the shortcomings of joint disease therapy.", EXPERT OPINION ON DRUG DELIVERY, (20090109), vol. 6, no. 1, doi:0.1517/17425240802647259, ISSN 1744-7593, pages 17 - 26, XP002808953

DOI:   http://dx.doi.org/0.1517/17425240802647259
by applicantUS5747060
 WO2006066419
    - GEORGE NUKMB, FRCP, "Colchicine: its Mechanism of Action and Efficacy in Crystal-Induced Inflammation", Current Rheumatology Reports, (20080000), vol. 10, pages 218 - 227
    - DAS, G. S. et al., "Colchicine Encapsulation within Poly(Ethylene Glycol)-Coated Poly(Lactic Acid)/Poly(s-Caprolactone) Microspheres-Controlled Release Studies", Drug Delivery, (20000000), vol. 7, no. 7544, doi:10.1080/10717540050120160, pages 129 - 138, XP055562692

DOI:   http://dx.doi.org/10.1080/10717540050120160
    - GRADUS-PIZLO IRMINA et al., "local delivery of biodegradable microcapsules containing colchicine or a colchicine analogue: effects on restenosis and implications of catheter-based drug delivery", Journal of The American College of Cardiology, vol. 26, no. 6, doi:10.1016/0735-1097(95)00345-2, pages 1549 - 1557, XP029665111

DOI:   http://dx.doi.org/10.1016/0735-1097(95)00345-2
    - RICHETTE, P. et al., "2016 updated EULAR evidence-based recommendations for the management of gout", Ann. Rheum. Dis., (20170000), vol. 76, pages 29 - 42
    - ABOUMANEI et al., "intra-articular formulation of colchicine loaded nanoemulsion systems for enhanced locoregional drug delivery", vitro characterization, Tc coupling and in vivo biodistribution studies
    - DECRISTOFORO et al., "The influence of chelator on the pharmacokinetics of 99mTc-labelled peptides", Q. J. NUCL. MED., (20020000), vol. 46, no. 3, pages 195 - 205, XP008051358
    - NUKI, G. COLCHICINE, "Its mechanism of action and efficacy in crystal-induced inflammation", Curr. Rheumatol. Rep., (20080000), vol. 10, pages 218 - 227
    - WALLACE SLS. J. REVIEW, "systemic toxicity associated with the intravenous administration of colchicine - guidelines for use", J Rheumatol., (19880000), vol. 15, pages 495 - 9
    - BONNEL, R. A.VILLALBA, M. L.KARWOSKI, C. B.BEITZ, J., "Deaths associated with inappropriate intravenous colchicine administration", J. Emerg. Med., (20020000), vol. 22, pages 385 - 387
    - ZHANG, W. et al., "EULAR evidence-based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT", Ann. Rheum. Dis., (20060000), vol. 65, pages 1312 - 1324
    - E.NIEL et al., "Colchicine today", Joint Bone Spine, (20060000), vol. 73, doi:10.1016/j.jbspin.2006.03.006, pages 672 - 678, XP028072909

DOI:   http://dx.doi.org/10.1016/j.jbspin.2006.03.006
    - TERKELTAUB, R. A. et al., "High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study", Arthritis Rheum., (20100000), vol. 62, pages 1060 - 1068
    - PETIT, A.REDOUT, E. M.VAN DE LEST, C. H.DE GRAUW, J. C.MULLER, B.MEYBOOM, R.VAN MIDWOUD, P.VERMONDEN, THENNINK, W. E.RENE VAN WEEREN, P., "Sustained intra-articular release of celecoxib from in situ forming gels made of acetyl-capped PCLA-PEG-PCLA triblock copolymers in horses", Biomaterials, vol. 53, doi:10.1016/j.biomaterials.2015.02.109, (20150000), pages 426 - 436, URL: https://doi.org/10.1016/i.biomaterials.2015.02.109, XP055346147

DOI:   http://dx.doi.org/10.1016/j.biomaterials.2015.02.109
    - WORBOYS PDWONG SLBARRIERE SL, "Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment", Eur J Clin Pharmacol, (20150600), vol. 71, no. 6, pages 707 - 714
    - L. RAHNFELD et al., "Injectable Lipid-Based Depot Formulations: Where Do We Stand?", Pharmaceutics, (20200000), vol. 12, no. 6, page 567
    - S. KEMPE et al., "In-situ forming implants-an attractive formulation principle for parenteral depot formulations", Journal of Controlled Release, (20120000), vol. 161, doi:10.1016/j.jconrel.2012.04.016, page 668, XP028492692

DOI:   http://dx.doi.org/10.1016/j.jconrel.2012.04.016
    - SCHOUBBEN, ARICCI, M.GIOVAGNOLI, S, "Meeting the unmet: from traditional to cutting-edge techniques for poly lactide and poly lactide-co-glycolide microparticle manufacturing", J. Pharm. Investig., (20190000), vol. 49, doi:10.1007/s40005-019-00446-y, pages 381 - 404, XP036893217

DOI:   http://dx.doi.org/10.1007/s40005-019-00446-y
    - GIOVAGNOLI, S. et al., "Physicochemical characterization and release mechanism of a novel prednisone biodegradable microsphere formulation", J Pharm Sci., (20080000), vol. 97, pages 303 - 317
    - K.S. OH et al., "Preclinical studies of ropivacaine extended-release from a temperature responsive hydrogel for prolonged relief of pain at the surgical wound", Int. J. of. Pharmaceutics, (20190000), vol. 558, doi:10.1016/j.ijpharm.2019.01.011, pages 225 - 230, XP085598494

DOI:   http://dx.doi.org/10.1016/j.ijpharm.2019.01.011
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.